Quest Diagnostics | DGX - Ebitda


Quest Diagnostics reported $648M in EBITDA for its fiscal quarter ending in June of 2026.





Ebitda Change Date
Acadia Healthcare USD 149.19M 4.97M Jun/2026
Agilent USD 456M 84M Dec/2025
Baxter International USD 309M 756M Mar/2026
Bruker USD 143.2M 33.2M Jun/2026
Cardinal Health USD 1.09B 109M Mar/2026
Centene USD 1.55B 1.01B Jun/2026
Charles River Laboratories USD 229.8M 28.26M Mar/2026
Cigna USD 3.28B 416M Mar/2026
Community Health Systems USD 395M 19M Dec/2025
CVS Health USD 5.85B 25M Jun/2026
Danaher USD 1.84B 81M Jun/2026
DaVita Healthcare Partners USD 746.81M 86.98M Jun/2026
Elevance Health USD 4.21B 2.02B Mar/2026
Encompass Health USD 348.8M 13.2M Mar/2026
HCA USD 4.03B 225M Jun/2026
Henry Schein USD 288M 1000K Jun/2026
Humana USD 2.06B 2.35B Mar/2026
Illumina USD 330M 80M Jun/2026
IQVIA Holdings USD 994M 62M Jun/2026
Laboratory Of America USD 767.7M 162.1M Jun/2026
McKesson USD 2.38B 501M Mar/2026
Mettler Toledo International USD 322.64M 43.66M Jun/2026
Molina Healthcare USD 197M 70M Jun/2026
Owens Minor USD 90.02M 2.15M Dec/2025
Pediatrix Medical Group USD 65.84M 21.47M Dec/2025
Quest Diagnostics USD 648M 91M Jun/2026
Revvity USD 228.18M 44.73M Jun/2026
Tenet Healthcare USD 1.3B 142M Jun/2026
Thermo Fisher Scientific USD 3.55B 845M Jun/2026
UnitedHealth USD 9.43B 567M Jun/2026
Universal Health Services USD 677.87M 17.36M Jun/2026
Veradigm USD 38.81M 29.61M Sep/2022
Waters USD 712M 545M Jun/2026
Zoetis USD 939M 101M Dec/2025